Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
OneSpan to Announce Second Quarter Financial Results on August 1, 2024
-
Soluna Announces Monthly Business Update
-
IMC Commits to Donate $30 Million to Room to Read in 2024-2028
-
Elevar Therapeutics Reports Plans for Near-Term Resubmission of NDA for First-Line Treatment Option for Unresectable Hepatocellular Carcinoma Following Type A FDA Meeting
-
Discrepancy AI partners with SingleKey to improve North American rental applications with artificial intelligence
-
Twist Bioscience Launches Synthetic RNA Control for H5N1 Influenza A
-
OutSystems Leads in Enterprise Low-Code Grid for Fourth Consecutive Year in G2 Software Marketplace
-
ON24 Announces Date for Second Quarter 2024 Earnings Release and Conference Call
-
Planet DDS Invests in Emerging Dental Groups with New Launchpad Program
-
Nasuni Announces Majority Investment Led by Vista Equity Partners at $1.2 Billion Valuation
-
Cotiviti’s Quality Intelligence Earns NCQA Certified Measures Status for HEDIS® Measurement Year 2024
-
Iveda Signs Strategic Partnership with Arab Organization of Industrialization and ZeroTech
-
VitalEdge Strengthens Client Support with Strategic Investments and Key Appointments
-
Steve Huntley Joins AXISS Audio USA as VP of Business Development
-
Emera Teleconference on August 9 to Discuss Q2 2024 Results
-
IntegriChain Acquires Federal Compliance Solutions, Creating Pharma's Deepest Contracts & Pricing and Gross-to-Net Advisory and Outsourcing Team
-
Perfect Corp. Announces New Upgraded HD AI Skin Analysis Solution, Empowering Hyper-Personalized Skincare Recommendations
-
Sylvamo to Release Second Quarter Earnings Aug. 9
-
Thoughtworks Launches SDV Pulse Report with AWS to Help Companies Navigate Transition to SDV
-
The Cigna Group Publishes 2023 ESG Report, Furthering Its Commitment to Advancing Better Health for All
-
Revvity To Hold Earnings Call on Monday, July 29, 2024
-
Oasis Sends Questionnaire to Ain Regarding Recent Scandal and Condemns Ain’s Acquisition of Francfranc (Stock Code: 9627 JT)
-
RedHill Biopharma Terminates License Agreement for Aemcolo®
-
AtriCure to Announce Second Quarter 2024 Financial Results
-
JumpCloud Dominates 2024 G2 Summer Grid® Reports, Leading in Record Number of Identity, Access, and Device Management Categories
-
Lazard to Announce Second Quarter and First-Half 2024 Financial Results
-
FIS Recognized as a Leading Industry Innovator for Treasury & Risk Solutions
-
Green Plains and Tharaldson Ethanol Announce Successful Start-Up of MSC™ System
-
Howmet Aerospace to Host Webcast and Announce Second Quarter 2024 Results
-
Skillsoft Collaborates with Microsoft to Develop Generative AI Skilling Program
-
Imbrium Therapeutics Achieves Last Patient Last Visit in Clinical Trial of Potential Treatment for Overactive Bladder Syndrome
-
UL Solutions Acquires Germany-Based Hydrogen Testing Company TesTneT
-
NICE Announces International CX Excellence Award Winners, Demonstrating CX AI Mastery
-
DHA, Housing Solutions for North Texas Dedicates Its West Dallas Headquarters Building to Former HUD Secretary Alphonso Jackson
-
Kiavi Selects AppraisalWorks™ as Appraisal Management Technology Partner, Implements Platform for Enhanced Operational Efficiency
-
Herc Holdings Announces Second Quarter 2024 Earnings Call and Webcast Date
-
Jeff McDermott Joins Energy Impact Partners as Head of Strategic Finance
-
VSee Health Now Providing Outpatient Telehealth Services to the Federal Bureau of Prisons
-
Montage Partners Appoints Ben Jenks as Director of Business Development
-
Boeing, Confluent, and Tesla Rank Among the Most Shorted Securities in June, Finds Hazeltree Shortside Crowdedness Report
-
BlastRADIUS Vulnerability Threatens Corporate Networks and Cloud – InkBridge Networks Guides Organizations Through the Fix
-
Unity Announces Second Quarter 2024 Financial Results Webcast
-
Service Properties Trust Second Quarter 2024 Conference Call Scheduled for Wednesday, August 7th
-
VYNE Therapeutics Announces Appointment of Subhashis Banerjee, M.D. as Senior Vice President of Clinical Development
-
Obsidian Therapeutics Announces FDA Fast Track Designation for OBX-115 for the Treatment of Advanced Melanoma
-
Pulnovo Medical Announces Joining PHA's (Pulmonary Hypertension Association) Corporate Committee
-
Fresh Del Monte Named 2024 SEAL Business Sustainability Award Winner
-
Jaguar Gene Therapy to Initiate Inaugural Pediatric Clinical Trial Targeting a Genetic Form of Autism Spectrum Disorder and Phelan-McDermid Syndrome
-
BGC Group to Report Second Quarter 2024 Financial Results on July 30, 2024
-
Oscar Health, Inc. 2024 Second Quarter Conference Call

